Juvenescence
juvlabs.comDeveloper of medical therapies designed to treat diseases of aging and increase human longevity.
Last Round
Aug 2019
Series B
Series B · $500.0M
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...